Tapewire

NYSE · USD

BIO

BIO-RAD LABORATORIES, INC.

Export transactions ↓
Tapewire entity
2247
SEC CIK
0000012208
Parsed reports
438

Last 12 months

Inside the activity.

0 purchase rows · 2 sale rows

Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.
Monthly counts
MonthPurchasesSales
Nov 202501
Dec 202500
Jan 202600
Feb 202600
Mar 202600
Apr 202600
May 202601
Jun 202600
Jul 202600
Aug 202600
Sep 202600
Oct 202600

Latest available

Insider transactions

JSON API
Reset

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction dateOwner / reported roleActivity / securityShares / unitsReported priceReported valueDetails
September 11, 2018 Filed Sep 13, 2018 20:13 UTC
STARK JAMES RVP, Corporate Controller
Exercise / conversionRestricted Stock Units · Derivative 200 $0.00 Strike: $0.00 $0.00
Disclosure

SEC source: 0001652252-18-000083 · edgar.xml · derivative · entry 3

STARK JAMES R · CIK 0001248083 · VP, Corporate Controller

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Bio-Rad A Common Stock · 200 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Bio-Rad Class A common stock.

F3 · derivative.exercise_date: The restricted stock units vest in five equal annual installments beginning September 11, 2014.

F3 · derivative.expiration_date: The restricted stock units vest in five equal annual installments beginning September 11, 2014.

Read SEC document
September 11, 2018 Filed Sep 13, 2018 20:13 UTC
STARK JAMES RVP, Corporate Controller
Tax withholdingBio-Rad A Common Stock 174 $308.37 $53,656.38
Disclosure

SEC source: 0001652252-18-000083 · edgar.xml · nonDerivative · entry 2

STARK JAMES R · CIK 0001248083 · VP, Corporate Controller

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 848

Read SEC document
September 11, 2018 Filed Sep 13, 2018 20:13 UTC
STARK JAMES RVP, Corporate Controller
Exercise / conversionBio-Rad A Common Stock 500 $0.00 $0.00
Disclosure

SEC source: 0001652252-18-000083 · edgar.xml · nonDerivative · entry 1

STARK JAMES R · CIK 0001248083 · VP, Corporate Controller

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,022

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · shares: Shares of Class A common stock acquired on the vesting of restricted stock units.

Read SEC document
September 11, 2018 Filed Sep 13, 2018 20:17 UTC Exercise / conversionRestricted Stock Units · Derivative 500 $0.00 Strike: $0.00 $0.00
Disclosure

SEC source: 0001652252-18-000085 · edgar.xml · derivative · entry 4

TSINGOS CHRISTINE A · CIK 0001278861 · EVP and CFO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,000

Underlying: Bio-Rad A Common Stock · 500 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Bio-Rad Class A common stock.

F4 · derivative.exercise_date: The restricted stock units vest in five equal annual installments beginning September 11, 2016.

F4 · derivative.expiration_date: The restricted stock units vest in five equal annual installments beginning September 11, 2016.

Read SEC document
September 11, 2018 Filed Sep 13, 2018 20:17 UTC Exercise / conversionRestricted Stock Units · Derivative 160 $0.00 Strike: $0.00 $0.00
Disclosure

SEC source: 0001652252-18-000085 · edgar.xml · derivative · entry 3

TSINGOS CHRISTINE A · CIK 0001278861 · EVP and CFO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Bio-Rad A Common Stock · 160 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Bio-Rad Class A common stock.

F3 · derivative.exercise_date: The restricted stock units vest in five equal annual installments beginning September 11, 2014.

F3 · derivative.expiration_date: The restricted stock units vest in five equal annual installments beginning September 11, 2014.

Read SEC document
September 11, 2018 Filed Sep 13, 2018 20:17 UTC Tax withholdingBio-Rad A Common Stock 229 $308.37 $70,616.73
Disclosure

SEC source: 0001652252-18-000085 · edgar.xml · nonDerivative · entry 2

TSINGOS CHRISTINE A · CIK 0001278861 · EVP and CFO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 8,094.0979

Read SEC document
September 11, 2018 Filed Sep 13, 2018 20:17 UTC Exercise / conversionBio-Rad A Common Stock 660 $0.00 $0.00
Disclosure

SEC source: 0001652252-18-000085 · edgar.xml · nonDerivative · entry 1

TSINGOS CHRISTINE A · CIK 0001278861 · EVP and CFO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 8,323.0979

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · shares: Shares of Class A common stock acquired on the vesting of restricted stock units.

Read SEC document
September 11, 2018 Filed Sep 13, 2018 20:08 UTC
Magni GiovanniEVP, Chief Strategy Officer
Exercise / conversionRestricted Stock Units · Derivative 500 $0.00 Strike: $0.00 $0.00
Disclosure

SEC source: 0001652252-18-000081 · edgar.xml · derivative · entry 4

Magni Giovanni · CIK 0001292816 · EVP, Chief Strategy Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,000

Underlying: Bio-Rad A Common Stock · 500 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Bio-Rad Class A common stock.

F4 · derivative.exercise_date: The restricted stock units vest in five equal annual installments beginning September 11, 2016.

F4 · derivative.expiration_date: The restricted stock units vest in five equal annual installments beginning September 11, 2016.

Read SEC document
September 11, 2018 Filed Sep 13, 2018 20:08 UTC
Magni GiovanniEVP, Chief Strategy Officer
Exercise / conversionRestricted Stock Units · Derivative 240 $0.00 Strike: $0.00 $0.00
Disclosure

SEC source: 0001652252-18-000081 · edgar.xml · derivative · entry 3

Magni Giovanni · CIK 0001292816 · EVP, Chief Strategy Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Bio-Rad A Common Stock · 240 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Bio-Rad Class A common stock.

F3 · derivative.exercise_date: The restricted stock units vest in five equal annual installments beginning September 11, 2014.

F3 · derivative.expiration_date: The restricted stock units vest in five equal annual installments beginning September 11, 2014.

Read SEC document
September 11, 2018 Filed Sep 13, 2018 20:08 UTC
Magni GiovanniEVP, Chief Strategy Officer
Tax withholdingBio-Rad A Common Stock 367 $308.37 $113,171.79
Disclosure

SEC source: 0001652252-18-000081 · edgar.xml · nonDerivative · entry 2

Magni Giovanni · CIK 0001292816 · EVP, Chief Strategy Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 11,920

Read SEC document
September 11, 2018 Filed Sep 13, 2018 20:08 UTC
Magni GiovanniEVP, Chief Strategy Officer
Exercise / conversionBio-Rad A Common Stock 740 $0.00 $0.00
Disclosure

SEC source: 0001652252-18-000081 · edgar.xml · nonDerivative · entry 1

Magni Giovanni · CIK 0001292816 · EVP, Chief Strategy Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 12,287

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · shares: Shares of Class A common stock acquired on the vesting of restricted stock units.

Read SEC document
September 11, 2018 Filed Sep 13, 2018 20:01 UTC
HUTTON RONALD WVice President and Treasurer
Exercise / conversionRestricted Stock Units · Derivative 150 $0.00 Strike: $0.00 $0.00
Disclosure

SEC source: 0001652252-18-000079 · edgar.xml · derivative · entry 4

HUTTON RONALD W · CIK 0001248073 · Vice President and Treasurer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 300

Underlying: Bio-Rad A Common Stock · 150 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Bio-Rad Class A common stock.

F4 · derivative.exercise_date: The restricted stock units vest in five equal annual installments beginning September 11, 2016.

F4 · derivative.expiration_date: The restricted stock units vest in five equal annual installments beginning September 11, 2016.

Read SEC document
September 11, 2018 Filed Sep 13, 2018 20:01 UTC
HUTTON RONALD WVice President and Treasurer
Exercise / conversionRestricted Stock Units · Derivative 150 $0.00 Strike: $0.00 $0.00
Disclosure

SEC source: 0001652252-18-000079 · edgar.xml · derivative · entry 3

HUTTON RONALD W · CIK 0001248073 · Vice President and Treasurer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Bio-Rad A Common Stock · 150 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Bio-Rad Class A common stock.

F3 · derivative.exercise_date: The restricted stock units vest in five equal annual installments beginning September 11, 2014.

F3 · derivative.expiration_date: The restricted stock units vest in five equal annual installments beginning September 11, 2014.

Read SEC document
September 11, 2018 Filed Sep 13, 2018 20:01 UTC
HUTTON RONALD WVice President and Treasurer
Tax withholdingBio-Rad A Common Stock 104 $308.37 $32,070.48
Disclosure

SEC source: 0001652252-18-000079 · edgar.xml · nonDerivative · entry 2

HUTTON RONALD W · CIK 0001248073 · Vice President and Treasurer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 3,999.6236

Read SEC document
September 11, 2018 Filed Sep 13, 2018 20:01 UTC
HUTTON RONALD WVice President and Treasurer
Exercise / conversionBio-Rad A Common Stock 300 $0.00 $0.00
Disclosure

SEC source: 0001652252-18-000079 · edgar.xml · nonDerivative · entry 1

HUTTON RONALD W · CIK 0001248073 · Vice President and Treasurer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 4,103.6236

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · shares: Shares of Class A common stock acquired on the vesting of restricted stock units.

Read SEC document
September 11, 2018 Filed Sep 13, 2018 19:53 UTC
Crowley MichaelEVP, GBL Commercial Operations
Exercise / conversionRestricted Stock Units · Derivative 600 $0.00 Strike: $0.00 $0.00
Disclosure

SEC source: 0001652252-18-000075 · edgar.xml · derivative · entry 4

Crowley Michael · CIK 0001629381 · EVP, GBL Commercial Operations

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,200

Underlying: Bio-Rad A Common Stock · 600 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Bio-Rad Class A common stock.

F4 · derivative.exercise_date: The restricted stock units vest in five equal annual installments beginning September 11, 2016.

F4 · derivative.expiration_date: The restricted stock units vest in five equal annual installments beginning September 11, 2016.

Read SEC document
September 11, 2018 Filed Sep 13, 2018 19:53 UTC
Crowley MichaelEVP, GBL Commercial Operations
Exercise / conversionRestricted Stock Units · Derivative 376 $0.00 Strike: $0.00 $0.00
Disclosure

SEC source: 0001652252-18-000075 · edgar.xml · derivative · entry 3

Crowley Michael · CIK 0001629381 · EVP, GBL Commercial Operations

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Bio-Rad A Common Stock · 376 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Bio-Rad Class A common stock.

F3 · derivative.exercise_date: The restricted stock units vest in five equal annual installments beginning September 11, 2014.

F3 · derivative.expiration_date: The restricted stock units vest in five equal annual installments beginning September 11, 2014.

Read SEC document
September 11, 2018 Filed Sep 13, 2018 19:53 UTC
Crowley MichaelEVP, GBL Commercial Operations
Tax withholdingBio-Rad A Common Stock 339 $308.37 $104,537.43
Disclosure

SEC source: 0001652252-18-000075 · edgar.xml · nonDerivative · entry 2

Crowley Michael · CIK 0001629381 · EVP, GBL Commercial Operations

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 3,817

Read SEC document
September 11, 2018 Filed Sep 13, 2018 19:53 UTC
Crowley MichaelEVP, GBL Commercial Operations
Exercise / conversionBio-Rad A Common Stock 976 $0.00 $0.00
Disclosure

SEC source: 0001652252-18-000075 · edgar.xml · nonDerivative · entry 1

Crowley Michael · CIK 0001629381 · EVP, GBL Commercial Operations

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 4,156

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · shares: Shares of Class A common stock acquired on the vesting of restricted stock units.

Read SEC document
September 11, 2018 Filed Sep 13, 2018 19:57 UTC
HERTIA JOHNExecutive Vice President
Exercise / conversionRestricted Stock Units · Derivative 600 $0.00 Strike: $0.00 $0.00
Disclosure

SEC source: 0001652252-18-000077 · edgar.xml · derivative · entry 5

HERTIA JOHN · CIK 0001616003 · Executive Vice President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,200

Underlying: Bio-Rad A Common Stock · 600 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Bio-Rad Class A common stock.

F4 · derivative.exercise_date: The restricted stock units vest in five equal annual installments beginning September 11, 2016.

F4 · derivative.expiration_date: The restricted stock units vest in five equal annual installments beginning September 11, 2016.

Read SEC document
September 11, 2018 Filed Sep 13, 2018 19:57 UTC
HERTIA JOHNExecutive Vice President
Exercise / conversionRestricted Stock Units · Derivative 700 $0.00 Strike: $0.00 $0.00
Disclosure

SEC source: 0001652252-18-000077 · edgar.xml · derivative · entry 4

HERTIA JOHN · CIK 0001616003 · Executive Vice President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Bio-Rad A Common Stock · 700 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Bio-Rad Class A common stock.

F3 · derivative.exercise_date: The restricted stock units vest in five equal annual installments beginning September 11, 2014.

F3 · derivative.expiration_date: The restricted stock units vest in five equal annual installments beginning September 11, 2014.

Read SEC document
September 11, 2018 Filed Sep 13, 2018 19:57 UTC
HERTIA JOHNExecutive Vice President
Tax withholdingBio-Rad A Common Stock 523 $308.37 $161,277.51
Disclosure

SEC source: 0001652252-18-000077 · edgar.xml · nonDerivative · entry 2

HERTIA JOHN · CIK 0001616003 · Executive Vice President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 14,515

Read SEC document
September 11, 2018 Filed Sep 13, 2018 19:57 UTC
HERTIA JOHNExecutive Vice President
Exercise / conversionBio-Rad A Common Stock 1,300 $0.00 $0.00
Disclosure

SEC source: 0001652252-18-000077 · edgar.xml · nonDerivative · entry 1

HERTIA JOHN · CIK 0001616003 · Executive Vice President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 15,038

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · shares: Shares of Class A common stock acquired on the vesting of restricted stock units.

Read SEC document
September 10, 2018 Filed Sep 12, 2018 23:39 UTC
SCHWARTZ NORMAN DDirector · Chairman, President, and CEO · 10% owner
Exercise / conversionRestricted Stock Units · Derivative 2,000 $0.00 Strike: $0.00 $0.00
Disclosure

SEC source: 0001652252-18-000073 · edgar.xml · derivative · entry 6

SCHWARTZ NORMAN D · CIK 0000940805 · Director · Chairman, President, and CEO · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 2,000

Underlying: Bio-Rad B Common Stock · 2,000 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F4 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Bio-Rad Class B common stock.

F5 · derivative.exercise_date: The restricted stock units vest in five equal annual installments beginning September 10, 2015.

F5 · derivative.expiration_date: The restricted stock units vest in five equal annual installments beginning September 10, 2015.

Read SEC document
September 10, 2018 Filed Sep 12, 2018 23:39 UTC
SCHWARTZ NORMAN DDirector · Chairman, President, and CEO · 10% owner
Tax withholdingBio-Rad B Common Stock 992 $308.00 $305,536.00
Disclosure

SEC source: 0001652252-18-000073 · edgar.xml · nonDerivative · entry 3

SCHWARTZ NORMAN D · CIK 0000940805 · Director · Chairman, President, and CEO · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 258,665

Read SEC document
September 10, 2018 Filed Sep 12, 2018 23:39 UTC
SCHWARTZ NORMAN DDirector · Chairman, President, and CEO · 10% owner
Exercise / conversionBio-Rad B Common Stock 2,000 $0.00 $0.00
Disclosure

SEC source: 0001652252-18-000073 · edgar.xml · nonDerivative · entry 2

SCHWARTZ NORMAN D · CIK 0000940805 · Director · Chairman, President, and CEO · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 259,657

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · shares: Shares of Class B common stock acquired on the vesting of restricted stock units.

Read SEC document
September 10, 2018 Filed Sep 12, 2018 21:06 UTC
TUMOLO ANNETTEExecutive Vice President
Exercise / conversionRestricted Stock Units · Derivative 400 $0.00 Strike: $0.00 $0.00
Disclosure

SEC source: 0001652252-18-000069 · edgar.xml · derivative · entry 3

TUMOLO ANNETTE · CIK 0001717996 · Executive Vice President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 400

Underlying: Bio-Rad A Common Stock · 400 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Bio-Rad Class A common stock.

F3 · derivative.exercise_date: The restricted stock units vest in five equal annual installments beginning September 10, 2015.

F3 · derivative.expiration_date: The restricted stock units vest in five equal annual installments beginning September 10, 2015.

Read SEC document
September 10, 2018 Filed Sep 12, 2018 21:06 UTC
TUMOLO ANNETTEExecutive Vice President
Tax withholdingBio-Rad A Common Stock 139 $308.00 $42,812.00
Disclosure

SEC source: 0001652252-18-000069 · edgar.xml · nonDerivative · entry 2

TUMOLO ANNETTE · CIK 0001717996 · Executive Vice President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 2,027.3476

Read SEC document
September 10, 2018 Filed Sep 12, 2018 21:06 UTC
TUMOLO ANNETTEExecutive Vice President
Exercise / conversionBio-Rad A Common Stock 400 $0.00 $0.00
Disclosure

SEC source: 0001652252-18-000069 · edgar.xml · nonDerivative · entry 1

TUMOLO ANNETTE · CIK 0001717996 · Executive Vice President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 2,166.3476

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · shares: Shares of Class A common stock acquired on the vesting of restricted stock units.

Read SEC document
September 10, 2018 Filed Sep 12, 2018 21:10 UTC
Crowley MichaelEVP, GBL Commercial Operations
Exercise / conversionRestricted Stock Units · Derivative 389 $0.00 Strike: $0.00 $0.00
Disclosure

SEC source: 0001652252-18-000071 · edgar.xml · derivative · entry 3

Crowley Michael · CIK 0001629381 · EVP, GBL Commercial Operations

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 389

Underlying: Bio-Rad A Common Stock · 389 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Bio-Rad Class A common stock.

F3 · derivative.exercise_date: The restricted stock units vest in five equal annual installments beginning September 10, 2015.

F3 · derivative.expiration_date: The restricted stock units vest in five equal annual installments beginning September 10, 2015.

Read SEC document
September 10, 2018 Filed Sep 12, 2018 21:10 UTC
Crowley MichaelEVP, GBL Commercial Operations
Tax withholdingBio-Rad A Common Stock 135 $308.00 $41,580.00
Disclosure

SEC source: 0001652252-18-000071 · edgar.xml · nonDerivative · entry 2

Crowley Michael · CIK 0001629381 · EVP, GBL Commercial Operations

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 3,180

Read SEC document
September 10, 2018 Filed Sep 12, 2018 21:10 UTC
Crowley MichaelEVP, GBL Commercial Operations
Exercise / conversionBio-Rad A Common Stock 389 $0.00 $0.00
Disclosure

SEC source: 0001652252-18-000071 · edgar.xml · nonDerivative · entry 1

Crowley Michael · CIK 0001629381 · EVP, GBL Commercial Operations

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 3,315

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · shares: Shares of Class A common stock acquired on the vesting of restricted stock units.

Read SEC document
September 10, 2018 Filed Sep 12, 2018 21:00 UTC Exercise / conversionRestricted Stock Units · Derivative 400 $0.00 Strike: $0.00 $0.00
Disclosure

SEC source: 0001652252-18-000066 · edgar.xml · derivative · entry 3

TSINGOS CHRISTINE A · CIK 0001278861 · EVP and CFO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 400

Underlying: Bio-Rad A Common Stock · 400 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Bio-Rad Class A common stock.

F3 · derivative.exercise_date: The restricted stock units vest in five equal annual installments beginning September 10, 2015.

F3 · derivative.expiration_date: The restricted stock units vest in five equal annual installments beginning September 10, 2015.

Read SEC document
September 10, 2018 Filed Sep 12, 2018 21:00 UTC Tax withholdingBio-Rad A Common Stock 139 $308.00 $42,812.00
Disclosure

SEC source: 0001652252-18-000066 · edgar.xml · nonDerivative · entry 2

TSINGOS CHRISTINE A · CIK 0001278861 · EVP and CFO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 7,663.0979

Read SEC document
September 10, 2018 Filed Sep 12, 2018 21:00 UTC Exercise / conversionBio-Rad A Common Stock 400 $0.00 $0.00
Disclosure

SEC source: 0001652252-18-000066 · edgar.xml · nonDerivative · entry 1

TSINGOS CHRISTINE A · CIK 0001278861 · EVP and CFO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 7,802.0979

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · shares: Shares of Class A common stock acquired on the vesting of restricted stock units.

Read SEC document
September 10, 2018 Filed Sep 12, 2018 20:55 UTC
STARK JAMES RVP, Corporate Controller
Exercise / conversionRestricted Stock Units · Derivative 200 $0.00 Strike: $0.00 $0.00
Disclosure

SEC source: 0001652252-18-000064 · edgar.xml · derivative · entry 3

STARK JAMES R · CIK 0001248083 · VP, Corporate Controller

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 200

Underlying: Bio-Rad A Common Stock · 200 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Bio-Rad Class A common stock.

F3 · derivative.exercise_date: The restricted stock units vest in five equal annual installments beginning September 10, 2015.

F3 · derivative.expiration_date: The restricted stock units vest in five equal annual installments beginning September 10, 2015.

Read SEC document
September 10, 2018 Filed Sep 12, 2018 20:55 UTC
STARK JAMES RVP, Corporate Controller
Tax withholdingBio-Rad A Common Stock 70 $308.00 $21,560.00
Disclosure

SEC source: 0001652252-18-000064 · edgar.xml · nonDerivative · entry 2

STARK JAMES R · CIK 0001248083 · VP, Corporate Controller

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 522

Read SEC document
September 10, 2018 Filed Sep 12, 2018 20:55 UTC
STARK JAMES RVP, Corporate Controller
Exercise / conversionBio-Rad A Common Stock 200 $0.00 $0.00
Disclosure

SEC source: 0001652252-18-000064 · edgar.xml · nonDerivative · entry 1

STARK JAMES R · CIK 0001248083 · VP, Corporate Controller

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 592

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · shares: Shares of Class A common stock acquired on the vesting of restricted stock units.

Read SEC document
September 10, 2018 Filed Sep 12, 2018 20:51 UTC
Magni GiovanniEVP, Chief Strategy Officer
Exercise / conversionRestricted Stock Units · Derivative 400 $0.00 Strike: $0.00 $0.00
Disclosure

SEC source: 0001652252-18-000062 · edgar.xml · derivative · entry 3

Magni Giovanni · CIK 0001292816 · EVP, Chief Strategy Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 400

Underlying: Bio-Rad A Common Stock · 400 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Bio-Rad Class A common stock.

F3 · derivative.exercise_date: The restricted stock units vest in five equal annual installments beginning September 10, 2015.

F3 · derivative.expiration_date: The restricted stock units vest in five equal annual installments beginning September 10, 2015.

Read SEC document
September 10, 2018 Filed Sep 12, 2018 20:51 UTC
Magni GiovanniEVP, Chief Strategy Officer
Tax withholdingBio-Rad A Common Stock 199 $308.00 $61,292.00
Disclosure

SEC source: 0001652252-18-000062 · edgar.xml · nonDerivative · entry 2

Magni Giovanni · CIK 0001292816 · EVP, Chief Strategy Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 11,547

Read SEC document
September 10, 2018 Filed Sep 12, 2018 20:51 UTC
Magni GiovanniEVP, Chief Strategy Officer
Exercise / conversionBio-Rad A Common Stock 400 $0.00 $0.00
Disclosure

SEC source: 0001652252-18-000062 · edgar.xml · nonDerivative · entry 1

Magni Giovanni · CIK 0001292816 · EVP, Chief Strategy Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 11,746

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · shares: Shares of Class A common stock acquired on the vesting of restricted stock units.

Read SEC document
September 10, 2018 Filed Sep 12, 2018 20:48 UTC
HUTTON RONALD WVice President and Treasurer
Exercise / conversionRestricted Stock Units · Derivative 150 $0.00 Strike: $0.00 $0.00
Disclosure

SEC source: 0001652252-18-000060 · edgar.xml · derivative · entry 3

HUTTON RONALD W · CIK 0001248073 · Vice President and Treasurer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 150

Underlying: Bio-Rad A Common Stock · 150 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Bio-Rad Class A common stock.

F3 · derivative.exercise_date: The restricted stock units vest in five equal annual installments beginning September 10, 2015.

F3 · derivative.expiration_date: The restricted stock units vest in five equal annual installments beginning September 10, 2015.

Read SEC document
September 10, 2018 Filed Sep 12, 2018 20:48 UTC
HUTTON RONALD WVice President and Treasurer
Tax withholdingBio-Rad A Common Stock 52 $308.00 $16,016.00
Disclosure

SEC source: 0001652252-18-000060 · edgar.xml · nonDerivative · entry 2

HUTTON RONALD W · CIK 0001248073 · Vice President and Treasurer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 3,803.6236

Read SEC document
September 10, 2018 Filed Sep 12, 2018 20:48 UTC
HUTTON RONALD WVice President and Treasurer
Exercise / conversionBio-Rad A Common Stock 150 $0.00 $0.00
Disclosure

SEC source: 0001652252-18-000060 · edgar.xml · nonDerivative · entry 1

HUTTON RONALD W · CIK 0001248073 · Vice President and Treasurer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 3,855.6236

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · shares: Shares of Class A common stock acquired on the vesting of restricted stock units.

Read SEC document
September 10, 2018 Filed Sep 12, 2018 20:10 UTC
HERTIA JOHNExecutive Vice President
Exercise / conversionRestricted Stock Units · Derivative 600 $0.00 Strike: $0.00 $0.00
Disclosure

SEC source: 0001652252-18-000058 · edgar.xml · derivative · entry 4

HERTIA JOHN · CIK 0001616003 · Executive Vice President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 600

Underlying: Bio-Rad A Common Stock · 600 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Bio-Rad Class A common stock.

F3 · derivative.exercise_date: The restricted stock units vest in five equal annual installments beginning September 10, 2015.

F3 · derivative.expiration_date: The restricted stock units vest in five equal annual installments beginning September 10, 2015.

Read SEC document
September 10, 2018 Filed Sep 12, 2018 20:10 UTC
HERTIA JOHNExecutive Vice President
Tax withholdingBio-Rad A Common Stock 208 $308.00 $64,064.00
Disclosure

SEC source: 0001652252-18-000058 · edgar.xml · nonDerivative · entry 2

HERTIA JOHN · CIK 0001616003 · Executive Vice President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 13,738

Read SEC document
September 10, 2018 Filed Sep 12, 2018 20:10 UTC
HERTIA JOHNExecutive Vice President
Exercise / conversionBio-Rad A Common Stock 600 $0.00 $0.00
Disclosure

SEC source: 0001652252-18-000058 · edgar.xml · nonDerivative · entry 1

HERTIA JOHN · CIK 0001616003 · Executive Vice President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 13,946

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · shares: Shares of Class A common stock acquired on the vesting of restricted stock units.

Read SEC document
September 08, 2018 Filed Sep 11, 2018 18:28 UTC
Magni GiovanniEVP, Chief Strategy Officer
Exercise / conversionRestricted Stock Units · Derivative 400 $0.00 Strike: $0.00 $0.00
Disclosure

SEC source: 0001652252-18-000048 · edgar.xml · derivative · entry 3

Magni Giovanni · CIK 0001292816 · EVP, Chief Strategy Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,200

Underlying: Bio-Rad A Common Stock · 400 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Bio-Rad Class A common stock.

F3 · derivative.exercise_date: The restricted stock units vest in five equal annual installments beginning September 8, 2017.

F3 · derivative.expiration_date: The restricted stock units vest in five equal annual installments beginning September 8, 2017.

Read SEC document
September 08, 2018 Filed Sep 11, 2018 18:28 UTC
Magni GiovanniEVP, Chief Strategy Officer
Tax withholdingBio-Rad A Common Stock 199 $313.74 $62,434.26
Disclosure

SEC source: 0001652252-18-000048 · edgar.xml · nonDerivative · entry 2

Magni Giovanni · CIK 0001292816 · EVP, Chief Strategy Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 11,346

Read SEC document
September 08, 2018 Filed Sep 11, 2018 18:28 UTC
Magni GiovanniEVP, Chief Strategy Officer
Exercise / conversionBio-Rad A Common Stock 400 $0.00 $0.00
Disclosure

SEC source: 0001652252-18-000048 · edgar.xml · nonDerivative · entry 1

Magni Giovanni · CIK 0001292816 · EVP, Chief Strategy Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 11,545

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · shares: Shares of Class A common stock acquired on the vesting of restricted stock units.

Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.